There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and t...Expand abstract
- Publisher copy:
- Copyright date:
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
If you are the owner of this record, you can report an update to it here: Report update to this record